M. Mason Guest

1.4k total citations
53 papers, 905 citations indexed

About

M. Mason Guest is a scholar working on Pulmonary and Respiratory Medicine, Hematology and Physiology. According to data from OpenAlex, M. Mason Guest has authored 53 papers receiving a total of 905 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Pulmonary and Respiratory Medicine, 8 papers in Hematology and 8 papers in Physiology. Recurrent topics in M. Mason Guest's work include Blood properties and coagulation (20 papers), Radiopharmaceutical Chemistry and Applications (5 papers) and Thermoregulation and physiological responses (5 papers). M. Mason Guest is often cited by papers focused on Blood properties and coagulation (20 papers), Radiopharmaceutical Chemistry and Applications (5 papers) and Thermoregulation and physiological responses (5 papers). M. Mason Guest collaborates with scholars based in United States, Canada and Belgium. M. Mason Guest's co-authors include L.B. Nanninga, K.S. Kirby, R. J. Dellenback, Shu Chien, Magnus I. Gregersen, Shunichi Usami, John R. Derrick, Earl W. Ferguson, Richard G. Cooper and J. M. McKenzie and has published in prestigious journals such as Science, New England Journal of Medicine and Journal of Clinical Investigation.

In The Last Decade

M. Mason Guest

51 papers receiving 783 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M. Mason Guest United States 15 346 167 154 142 109 53 905
Clara M. Ambrus United States 19 317 0.9× 190 1.1× 85 0.6× 327 2.3× 149 1.4× 90 1.3k
A. A. Sharp United Kingdom 17 249 0.7× 114 0.7× 79 0.5× 415 2.9× 52 0.5× 46 1.2k
Märta Knös Germany 7 167 0.5× 134 0.8× 28 0.2× 200 1.4× 45 0.4× 11 697
Philip Kimbel United States 20 818 2.4× 271 1.6× 162 1.1× 94 0.7× 20 0.2× 42 1.4k
J Bignon France 21 777 2.2× 201 1.2× 140 0.9× 33 0.2× 23 0.2× 72 1.3k
J.E. Pierce United States 16 243 0.7× 277 1.7× 78 0.5× 155 1.1× 12 0.1× 31 934
Benditt Ep United States 20 163 0.5× 379 2.3× 127 0.8× 58 0.4× 11 0.1× 33 1.1k
Hiroshi Takahashi Japan 18 318 0.9× 360 2.2× 30 0.2× 80 0.6× 85 0.8× 101 1.2k
Robert L. Rosenthal United States 16 116 0.3× 170 1.0× 41 0.3× 414 2.9× 23 0.2× 48 1.0k
Duncan P. Thomas United States 20 263 0.8× 104 0.6× 45 0.3× 458 3.2× 33 0.3× 43 1.5k

Countries citing papers authored by M. Mason Guest

Since Specialization
Citations

This map shows the geographic impact of M. Mason Guest's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Mason Guest with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Mason Guest more than expected).

Fields of papers citing papers by M. Mason Guest

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Mason Guest. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Mason Guest. The network helps show where M. Mason Guest may publish in the future.

Co-authorship network of co-authors of M. Mason Guest

This figure shows the co-authorship network connecting the top 25 collaborators of M. Mason Guest. A scholar is included among the top collaborators of M. Mason Guest based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Mason Guest. M. Mason Guest is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lin, Fanching, Takeru Ehara, Steven V. Horton, et al.. (2024). Peptide Binder to Glypican-3 as a Theranostic Agent for Hepatocellular Carcinoma. Journal of Nuclear Medicine. 65(4). 586–592. 29 indexed citations
2.
Li, Gary, Fanching Lin, Takeru Ehara, et al.. (2023). Novel peptide binder to Glypican-3 for targeted radiopharmaceutical therapy of hepatocellular carcinoma.. Journal of Clinical Oncology. 41(16_suppl). e16131–e16131. 1 indexed citations
3.
Richardson, Samantha J., Takeru Ehara, M. Mason Guest, et al.. (2023). Novel peptide binder for EphA2-targeted radiopharmaceutical therapy for multiple solid tumors.. Journal of Clinical Oncology. 41(16_suppl). e15113–e15113.
4.
Guest, M. Mason, et al.. (1999). Core decompression of steroid induced avascular necrosis of the talus. The Foot. 9(1). 44–46. 3 indexed citations
5.
Guest, M. Mason, et al.. (1991). Burn Trauma: Role of Thrombocytopenia in Inhibition of Megakaryocytopoiesis. Annals of the New York Academy of Sciences. 628(1). 396–398. 4 indexed citations
6.
Guest, M. Mason, D’Arcy J. Wainwright, & M.E. Frazier. (1983). Research: Role of Denatured Fibrinogen and Other Components of Blood and Vessel Walls in the Sequelae of Burn Injury. Journal of Burn Care & Rehabilitation. 4(3). 158–162. 1 indexed citations
7.
Hayashi, Masachika, et al.. (1979). Pulmonary microcirculation following full-thickness burns. Burns. 5(3). 227–235. 3 indexed citations
8.
Nanninga, L.B. & M. Mason Guest. (1979). Purification and Properties of an Antiactivator Fraction from Bovine Serum. Thrombosis and Haemostasis. 42(3). 855–863. 4 indexed citations
9.
Wells, C.H., et al.. (1979). Tissue gas and blood analyses of human subjects breathing 80% argon and 20% oxygen.. PubMed. 50(4). 357–62. 7 indexed citations
10.
Hayashi, Masachika, et al.. (1976). Effects of mannitol and nicotinic acid on renal papillary blood flow in burned hamsters. Burns. 2(4). 245–249. 1 indexed citations
11.
Nanninga, L.B. & M. Mason Guest. (1971). Antiactivator (Antikinase) Activity of Human Plasma and Its Blocking by Parachloromercuribenzoate and Salicylate. Thrombosis and Haemostasis. 26(3). 541–556. 2 indexed citations
12.
Monto, Raymond W., et al.. (1969). Observations on the mechanism of hemorrhagic toxicity in mithramycin (NSC 24559) therapy.. PubMed. 29(3). 697–704. 27 indexed citations
13.
Nanninga, L.B. & M. Mason Guest. (1968). Antifibrinolytic Action of the Anticoagulant Split Product of Fibrinogen. Thrombosis and Haemostasis. 19(03/04). 526–532. 2 indexed citations
14.
Guest, M. Mason, et al.. (1965). Coagulation and fibrinolytic studies in women receiving an anovulatory drug (medroxyprogesterone acetate with estradiol). American Journal of Obstetrics and Gynecology. 93(2). 167–172. 14 indexed citations
15.
McKenzie, J. M., et al.. (1963). Fibrinogen titer as an indicator of physiologic stability. American Journal of Physiology-Legacy Content. 204(1). 42–44. 14 indexed citations
16.
Guest, M. Mason, et al.. (1962). Stability of Fibrin Contiguous to Intima of Veins. Circulation Research. 11(5). 832–837. 16 indexed citations
17.
Levin, William C., et al.. (1962). Mild Hemophilia Affecting Both Males and Females. New England Journal of Medicine. 266(5). 220–223. 9 indexed citations
18.
Guest, M. Mason, et al.. (1959). Assay of canine profibrinolysin (plasminogen). American Journal of Physiology-Legacy Content. 197(2). 391–395. 2 indexed citations
19.
Mohler, Stanley R., et al.. (1957). Distribution of Urokinase Among the Common Mammals. American Journal of Physiology-Legacy Content. 192(1). 186–190. 14 indexed citations
20.
Guest, M. Mason, et al.. (1955). The application of foam technique to the partial purification of a urine activator of plasma profibrinolysin. Archives of Biochemistry and Biophysics. 55(1). 286–287. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026